TERATOGENESIS BY RETINOIC ACID ANALOGS POSITIVELY CORRELATES WITH ELEVATION OF RETINOIC ACID RECEPTOR-BETA-2 MESSENGER-RNA LEVELS IN TREATED EMBRYOS

被引:31
作者
JIANG, H
GYDA, M
HARNISH, DC
CHANDRARATNA, RA
SOPRANO, KJ
KOCHHAR, DM
SOPRANO, DR
机构
[1] TEMPLE UNIV,SCH MED,DEPT BIOCHEM,PHILADELPHIA,PA 19140
[2] THOMAS JEFFERSON UNIV,DEPT ANAT & DEV BIOL,PHILADELPHIA,PA 19107
[3] TEMPLE UNIV,SCH MED,FELS INST CANC RES & MOLEC BIOL,PHILADELPHIA,PA 19140
[4] TEMPLE UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19140
[5] ALLERGAN PHARMACEUT INC,DISCOVERY RES,IRVINE,CA 92713
关键词
D O I
10.1002/tera.1420500106
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Retinoic acid (RA) plays an important role during normal embryogenesis, however high doses of RA are teratogenic. Retinoic acid receptor-beta 2 (RAR-beta 2) mRNA and protein levels were previously demonstrated to undergo rapid elevation in susceptible tissues after treatment with teratogenic doses of RA. In this report we compared the effects of a number of retinoids, which represent a wide va rie?l of chemical structures and which differ in their teratogenic potencies, on RAR-beta 2 mRNA levels in mouse embryos 6 hr after treatment. Retinoid treatments which result in a high incidence of limb defects elevated RAR-beta 2 mRNA levels similarly (10-14 fold in the limb buds, 4-8 fold in the head, and 2-4 fold in the remainder of the body). On the other hand, retinoid treatments which cause a low or no incidence of limb defects resulted in minor changes in RAR-beta 2 mRNA levels in each embryonic region. Therefore, a strong positive correlation was found between the elevation of RAR-beta 2 mRNA levels and the retinoids which produce limb defects. This provides further evidence that an elevation of RAR-beta 2 mRNA levels, and subsequently protein levels, is an important event involved in mediating the effects of RA during dysmorphogenesis. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 42 条
[21]   RETINOIC ACID EMBRYOPATHY [J].
LAMMER, EJ ;
CHEN, DT ;
HOAR, RM ;
AGNISH, ND ;
BENKE, PJ ;
BRAUN, JT ;
CURRY, CJ ;
FERNHOFF, PM ;
GRIX, AW ;
LOTT, IT ;
RICHARD, JM ;
SUN, SC .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (14) :837-841
[22]  
LEHMANN JM, 1991, CANCER RES, V51, P4804
[23]   PURIFICATION, CLONING, AND RXR IDENTITY OF THE HELA-CELL FACTOR WITH WHICH RAR OR TR HETERODIMERIZES TO BIND TARGET SEQUENCES EFFICIENTLY [J].
LEID, M ;
KASTNER, P ;
LYONS, R ;
NAKSHATRI, H ;
SAUNDERS, M ;
ZACHAREWSKI, T ;
CHEN, JY ;
STAUB, A ;
GARNIER, JM ;
MADER, S ;
CHAMBON, P .
CELL, 1992, 68 (02) :377-395
[24]   MULTIPLE ISOFORMS OF THE MOUSE RETINOIC ACID RECEPTOR ALPHA ARE GENERATED BY ALTERNATIVE SPLICING AND DIFFERENTIAL INDUCTION BY RETINOIC ACID [J].
LEROY, P ;
KRUST, A ;
ZELENT, A ;
MENDELSOHN, C ;
GARNIER, JM ;
KASTNER, P ;
DIERICH, A ;
CHAMBON, P .
EMBO JOURNAL, 1991, 10 (01) :59-69
[25]   9-CIS RETINOIC ACID STEREOISOMER BINDS AND ACTIVATES THE NUCLEAR RECEPTOR RXR-ALPHA [J].
LEVIN, AA ;
STURZENBECKER, LJ ;
KAZMER, S ;
BOSAKOWSKI, T ;
HUSELTON, C ;
ALLENBY, G ;
SPECK, J ;
KRATZEISEN, C ;
ROSENBERGER, M ;
LOVEY, A ;
GRIPPO, JF .
NATURE, 1992, 355 (6358) :359-361
[26]  
MANGELSDORF DJ, 1993, RETINOIDS, P319
[27]  
MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
[28]  
MENDELSOHN C, 1991, DEVELOPMENT, V113, P723
[29]   RAR-BETA-4, A RETINOIC ACID RECEPTOR ISOFORM IS GENERATED FROM RAR-BETA-2 BY ALTERNATIVE SPLICING AND USAGE OF A CUG INITIATOR CODON [J].
NAGPAL, S ;
ZELENT, A ;
CHAMBON, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :2718-2722
[30]   TERATOGEN UPDATE - VITAMIN-A CONGENERS [J].
ROSA, FW ;
WILK, AL ;
KELSEY, FO .
TERATOLOGY, 1986, 33 (03) :355-364